Founded in 2016, Meridian Street Capital focuses on early-stage healthcare investments in the United States. They have made 16 investments, with notable portfolio companies including Path, nOCD, and Valify. The firm has raised two funds, the latest being Meridian Street Ventures II, L.P., which raised $16.3M. They seek to invest in information technology, manufacturing, SaaS, and health technology sectors.